[Secondary hemophagocytic syndrome due to Peg-interferon administration]

Farm Hosp. 2014 Jan 1;38(1):73-4. doi: 10.7399/FH.2014.38.1.1129.
[Article in Spanish]
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antiviral Agents / adverse effects*
  • Antiviral Agents / therapeutic use
  • Hepatitis C / complications
  • Hepatitis C / drug therapy
  • Humans
  • Interferon-alpha / adverse effects*
  • Interferon-alpha / therapeutic use
  • Liver Transplantation
  • Lymphohistiocytosis, Hemophagocytic / chemically induced*
  • Male
  • Middle Aged
  • Polyethylene Glycols / adverse effects*
  • Polyethylene Glycols / therapeutic use
  • Recombinant Proteins / adverse effects
  • Recombinant Proteins / therapeutic use

Substances

  • Antiviral Agents
  • Interferon-alpha
  • Recombinant Proteins
  • Polyethylene Glycols
  • peginterferon alfa-2a